Press Release: Ovarian Cancer Advocates Applaud Findings on Aspirin and Risk Reduction


Further Study Needed Before Clinical Recommendations Change

Washington, DC—A study published yesterday by the National Institutes of Health found that women who took aspirin on a daily basis had a 20 percent reduction in risk of ovarian cancer. The Ovarian Cancer National Alliance released the following statement in response to the study.

“This is amazing news for our community—and for all women who are at risk of ovarian cancer,” said Alliance CEO Calaneet Balas. “Further study is needed to confirm the results, but it is encouraging to know that anti-inflammatory drugs likely reduce women’s risk of developing this disease. Ovarian cancer is the deadliest gynecologic cancer, taking the lives of more than 14,000 women each year. We applaud the news that women could use readily available, over-the-counter medications to cut their risk.”

Click here for more information about ovarian cancer risk.

The Ovarian Cancer National Alliance is a powerful voice for everyone touched by ovarian cancer. We connect survivors, women at risk, caregivers and health providers with the information and resources they need. We ensure that ovarian cancer is a priority for lawmakers and agencies in Washington, DC, and throughout the country. We help our community raise their voices on behalf of every life that has been affected by this disease.


For more information, or to schedule an interview, please contact Amanda Davis at or (202)331-1332.

Posted on in OCRA News, Research